股息配發率   玩股撇步(動畫小學堂)

  • 現金殖利率: 2.02%、總殖利率: 2.02%、5年平均現金配發率: 166.66%
  • 要留意資產負債表的未分配盈餘和配息能力, 如果為負值, 可能會無法發放股利
  • 股利有2個稅要支出, 分別是綜合所得稅和健保補充保費(單筆股利達2萬元以上, 課2.11%)
EPS YoY現金股利 YoY股票股利 YoY現金配發率 YoY股票配發率 YoY全部配發率 YoY
2023 (10)-1.8100.50400.00.0000.0000.0000.000
2022 (9)0.03-97.170.1000.000333.3300.000333.330
2021 (8)1.0600.0000.0000.0000.0000.000
2020 (7)-0.9200.0000.0000.0000.0000.000
2019 (6)-0.6100.0000.0000.0000.0000.000
2018 (5)-0.8800.0000.0000.0000.0000.000
2017 (4)-0.3900.0000.0000.0000.0000.000
2016 (3)0.0800.0000.0000.0000.0000.000
每股盈餘-近20季
EPS QoQ YoY本業EPS QoQ YoY累計EPS QoQ YoY
23Q4 (20)-2.49-5080.0-536.840.951155.56480.0-1.81-366.18-6133.33
23Q3 (19)0.05-94.05-16.67-0.0964.035.710.687.94223.64
23Q2 (18)0.84500.0380.0-0.25-127.27-38.890.63400.0198.44
23Q1 (17)-0.21-136.8436.36-0.1156.0-22.22-0.21-800.036.36
22Q4 (16)0.57850.035.71-0.25-78.57-56.250.03105.45-97.17
22Q3 (15)0.06120.0-83.33-0.1422.22-600.0-0.5514.06-182.09
22Q2 (14)-0.309.09-168.18-0.18-100.0-212.5-0.64-93.94-306.45
22Q1 (13)-0.33-178.57-153.85-0.0943.75-550.0-0.33-131.13-153.85
21Q4 (12)0.4216.67231.25-0.16-700.0-220.01.0658.21215.22
21Q3 (11)0.36-18.18238.46-0.02-112.581.820.67116.13211.67
21Q2 (10)0.44438.46276.00.16700.0180.00.31338.46191.18
21Q1 (9)-0.1359.38-44.440.02140.0140.0-0.1385.87-44.44
20Q4 (8)-0.32-23.08-357.14-0.0554.5528.57-0.92-53.33-50.82
20Q3 (7)-0.26-4.0-44.44-0.1145.00.0-0.60-76.47-11.11
20Q2 (6)-0.25-177.78-31.58-0.20-300.0-122.22-0.34-277.785.56
20Q1 (5)-0.09-28.5747.06-0.0528.5754.55-0.0985.2547.06
19Q4 (4)-0.0761.110.0-0.0736.360.0-0.61-12.960.0
19Q3 (3)-0.185.260.0-0.11-22.220.0-0.54-50.00.0
19Q2 (2)-0.19-11.760.0-0.0918.180.0-0.36-111.760.0
19Q1 (1)-0.170.00.0-0.110.00.0-0.170.00.0
年/月營收月增率(%)去年同期年增率(%)累計營收累計營收年增率(%)近三月累計營收存貨銷售比備註(年增率變動50%需說明原因)
2024/20.05-63.78-74.330.19-24.80.38N/A因遇春節連假,交易日減少,故收入比去年同期減少
2024/10.14-29.03149.690.14149.690.54N/A因本期增加合併子公司營收,故比去年同期增加
2023/120.19-7.58133.72.31171.360.530.43因本期增加合併子公司營收,故比去年同期增加
2023/110.2160.99329.932.12175.420.540.42因本期增加合併子公司營收,故比去年同期增加
2023/100.13-36.43135.831.91164.960.550.41因本期增加合併子公司營收,故比去年同期增加
2023/90.2-6.86315.881.78167.380.60.31因本期增加合併子公司營收,故比去年同期增加
2023/80.2222.2180.061.57155.50.530.36因本期增加合併子公司營收,故比去年同期增加
2023/70.1834.4320.461.35151.910.560.34因本期增加合併子公司營收,故比去年同期增加
2023/60.13-45.9644.221.17202.540.630.29因本期增加合併子公司營收,故比去年同期增加
2023/50.250.32191.261.04252.340.790.23因本期增加合併子公司營收,故比去年同期增加
2023/40.25-16.54551.570.79277.080.740.24因本期增加合併子公司營收,故比去年同期增加
2023/30.352.55423.330.54216.630.540.39因本期增加合併子公司營收,故比去年用期增加
2023/20.19252.32267.620.25115.490.330.63因本期增加合併子公司營收,故比去年同期增加
2023/10.06-33.57-12.320.06-12.320.191.13-
2022/120.0870.0-12.270.85-17.960.190.21-
2022/110.05-11.683.960.77-18.530.150.26-
2022/100.0612.08-38.70.72-19.70.180.22-
2022/90.05-37.28-4.70.66-17.580.280.18-
2022/80.08-47.43-0.880.62-18.460.320.16-
2022/70.1560.9443.290.54-20.520.330.15-
2022/60.099.12-38.350.39-32.160.220.19-
2022/50.09124.43-20.770.29-29.940.180.22-
2022/40.04-32.97-59.390.21-33.080.150.27因疫情影響,進口藥物交期延宕所致
2022/30.067.16-37.630.17-21.950.170.12-
2022/20.05-15.97-13.790.12-11.00.210.1-
2022/10.06-33.53-8.520.06-8.520.20.1-
2021/120.09101.47-31.411.04-24.690.230.13-
2021/110.05-47.93-56.920.94-23.940.190.16因減少合併子公司故本月營收較同期減少
2021/100.0974.25-27.490.9-20.770.220.14-
2021/90.05-34.76-54.660.81-19.940.240.21因減少合併子公司故本月營收較同期減少
2021/80.08-24.0-42.130.76-15.510.330.15-
2021/70.1-30.76-24.150.68-10.70.360.14-
2021/60.1540.2560.170.57-7.790.350.28本月營收:西藥3,743;試劑8,630;租金收入1,034;售電收入697;其他951
2021/50.1115.03-31.430.42-19.940.290.34-
2021/40.092.94-17.70.31-15.070.250.41-
2021/30.0948.12-18.830.22-13.90.220.18-
2021/20.06-10.84-21.660.13-10.090.270.15-
2021/10.07-50.164.330.074.330.320.13本月營收:西藥2,954;租金收入3,270;售電收入639
2020/120.1426.52-22.191.38117.180.370.13本月營收:西藥2,959;租金收入3,005;售電收入512;顧問收入7,295
2020/110.11-12.36177.791.24171.090.350.14因合併子公司,故本月營收較去年同期增加.本月營收:西藥3,694;租金收入3,088;售電收入592;顧問收入3,510
2020/100.128.95281.881.13170.460.380.13因合併子公司,故本月營收較去年同期增加.本月營收:西藥7,919;租金收入2,742;售電收入806;顧問收入952
2020/90.11-16.73235.031.01161.070.390.13因合併子公司,故本月營收較去年同期增加.本月營收:西藥2,785;租金收入2,864;售電收入878;顧問收入4,871
2020/80.14-0.39247.340.89153.920.370.14因合併子公司,故本月營收較去年同期增加.本月營收:西藥4,472;租金收入2,764;售電收入738;其他-口罩286;顧問收入5,429
2020/70.1446.21241.610.76142.140.390.13因合併子公司,故本月營收較去年同期增加.本月營收:西藥4,931;租金收入1,827;售電收入966;顧問收入6,019
2020/60.09-39.96130.310.62127.640.360.19因合併子公司營收,故本月營收較去年同期增加.本月營收:西藥3,660;租金收入2,021;售電收入885;顧問收入2,833
2020/50.1638.08326.010.53127.170.380.18因合併子公司營收,故本月營收較去年同期增加.本月營收:西藥3,373;租金收入2,352;售電收入517;顧問收入9,414
2020/40.111.52669.190.3789.650.30.23因合併子公司營收,故本月營收較去年同期大幅增加.本月營收:西藥1,909;租金收入2,049;售電收入818;顧問收入6,562
2020/30.1142.97128.990.2642.210.260.35因合併子公司營收,故本月營收較去年同期營收增加。本月營收:西藥3,592;租金收入1,758;售電收入756;顧問收入5,062
2020/20.0818.74163.790.149.970.320.28因合併子公司營收,故本月營收較去年同期營收增加,本月營收:西藥2,488;租金收入1,467;售電收入713;顧問收入3,143
2020/10.07-62.83-35.30.07-35.30.280.32本月營收:西藥2,604;租金收入1,980;售電收入720;顧問收入1,274
2019/120.18351.76486.280.6318.160.250.4除本月業績增加外,另因合併子公司營收,故108年12月營收增加
2019/110.0420.4720.850.46-9.710.110.95-
2019/100.03-4.4-25.480.42-11.80.110.94-
2019/90.03-13.67-27.190.39-10.410.111.06-
2019/80.04-2.039.890.35-8.370.121.0-
2019/70.04-1.4212.180.31-10.250.121.02-
2019/60.0411.0413.80.27-12.830.091.84-
2019/50.04149.322.480.23-16.280.11.7-
2019/40.01-69.77-73.570.19-19.080.0N/A係因醫美耗材及儀器租金收入減少之故
2019/30.0564.7-5.130.18-2.640.0N/A-

股利相關資訊

免責聲明

本網站所有資料僅供參考,如使用者依本資料交易發生交易損失需自行負責,本網站對資料內容錯誤﹑更新延誤不負任何責任。